[CITATION][C] Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an …
SRD Johnston, R Hegg, SA Im - J Clin Oncol: Off J Am Soc Clin Oncol, 2018
[CITATION][C] Phase III, 569 Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) 570 Blockade With Lapatinib Plus Trastuzumab in …
SRD Johnston, R Hegg, SA Im, IH Park, O Burdaeva… - J Clin Oncol, 2021
